Review series: Aspects of interstitial lung disease: Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options

Pulse oximetry in scleroderma patients: concerns

(2010) R. Garg et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

Small changes in six-minute walk distance are important in diffuse parenchymal lung disease

(2009) Anne E. Holland et al.   RESPIRATORY MEDICINE

Exercise peripheral oxygen saturation (Spo2) accurately reflects arterial oxygen saturation (Sao2) and predicts mortality in systemic sclerosis

(2009) J J Swigris et al.   THORAX

Treatment of Idiopathic Pulmonary Fibrosis with Etanercept

(2008) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis

(2008) Charlene D. Fell et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pulmonary Rehabilitation in Interstitial Lung Disease

(2008) Alicia Ferreira et al.   CHEST

Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis

(2008) Sven Gläser et al.   RESPIRATORY MEDICINE

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis

(2008) Antonella Caminati et al.   RESPIRATORY MEDICINE

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis

(2008) Osamu NISHIYAMA et al.   RESPIROLOGY

Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease

(2008) A E Holland et al.   THORAX

BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

(2007) Talmadge E. King et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced fibrotic lung disease

(2007) V.A. Varney et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS